Skip to content
2023 FOCIS-SITC Cancer Immunity and Immunotherapy Course Evaluation
Program
Thank you for attending the course.
Please rate each session and speaker below. Your responses will be kept strictly confidential.
1.
Principles of Tumor Immunity - Abul Abbas, MD
Excellent
Good
Average
Poor
Comments
2.
Did you perceive bias?
Yes
No
If yes, please specify:
3.
The Tumor Microenvironment - Matthew Spitzer, PhD
Excellent
Good
Average
Poor
Comments
4.
Did you perceive bias?
Yes
No
If yes, please specify:
5.
B Cells - Tullia Bruno, PhD
Excellent
Good
Average
Poor
Comments
6.
Did you perceive bias?
Yes
No
If yes, please specify:
7.
T Cell Exhaustion - Mary Philip, MD, PhD
Excellent
Good
Average
Poor
Comments
8.
Did you perceive bias?
Yes
No
If yes, please specify:
9.
Immune-Mediated Toxicities - Alexandra-Chloe Villani, PhD
Excellent
Good
Average
Poor
Comments
10.
Did you perceive bias?
Yes
No
If yes, please specify:
11.
Shiny New CARs - Joshua Brody, MD
Excellent
Good
Average
Poor
Comments
12.
Did you perceive bias?
Yes
No
If yes, please specify:
13.
Tumor Vaccines - Catherine Wu, MD
Excellent
Good
Average
Poor
Comments
14.
Did you perceive bias?
Yes
No
If yes, please specify:
15.
Innovations with NK Cells - Rizwan Romee, MD
Excellent
Good
Average
Poor
Comments
16.
Did you perceive bias?
Yes
No
If yes, please specify:
17.
Combinatorial Therapeutics in Solid Tumors - Israel Lowy, MD, PhD
Excellent
Good
Average
Poor
Comments
18.
Did you perceive bias?
Yes
No
If yes, please specify:
19.
Challenges 1: Real-time Analysis of Tumor Immunotherapy Evasion - Shashank Patel, PhD
Excellent
Good
Average
Poor
Comments
20.
Did you perceive bias?
Yes
No
If yes, please specify:
21.
Challenges 2: Quantitative Analysis of CAR-T Cell Pharmacology and Response - Daniel Kirouac, PhD
Excellent
Good
Average
Poor
Comments
